TP53 and hepatocellular carcinoma: In HCC, Wang et al. (2020) showed a reduced RFS with post-operative ctDNA assessed according to a panel of four hotspot genomic mutations in TP53 (G747T), CTNNB1 (A121G, C133T), and TERT (c.-124C>T) [30].